INTRODUCTION
The "autonomy" of neoplastic tissue is intimately related to its ability to carry out net synthesis of protein regardless of the demands of the host. Clinically, this is manifest in the failure of the tumor to exhibit the wasting of other tissues of the cachectic host. Accordingly, Mider and others"8 have referred to tumors as "nitrogen traps." In experiments of LePage et al.1' on this subject, the weight of most nontumor tissues of fasted tumorbearing rates diminished to 30-50%o of values for control tissues. On the other hand, the increase in weight of tumors was not significantly different in fasted animals and those fed ad libitum. Moreover, the uptake of C14 in proteins of the tumors was equal in rate and quantity in fed and fasted tumor-bearing rats following injection of glycine-2-C'4.
Among the possible explanations for these clinical and laboratory findings, two have been investigated recently, namely, the possibility that tumors might have a peculiarly great avidity for amino acids of the blood and the possibility that tumors might take up plasma proteins directly. Initial evidence that tumors exhibited a greater uptake of amino acids came from the studies of Zamecnik et al.' who reported that hepatoma slices incorporated isotope of labeled alanine into protein at a rate eight times that of slices of normal liver or liver of the hepatoma-bearing rat. These findings have been confirmed by Winnick et al.,' but they are in sharp contrast to the results obtained after injection of labeled amino acids into tumorbearing rats. In 1944 Shemin and Rittenberg17 found that uptake of N15-labeled amino acids into protein in vivo was not greater in tumors Received ifor publication January 21, 1955. present studies provide further confirmation of the results of Shemin and Rittenberg. Utilization of plasma protein as a source of amino acids was demonstrated by Whipple and Madden who infused plasma into fasted dogs and maintained their nitrogen balance.' In the normal animal, the rate of turnover of plasma proteins is rapid, as is indicated by the turnover time of 8.2 days for albumin in the rat."9 While these findings have indicated that plasma proteins are utilized by nontumor tissues, evidence has only recently been presented for concentration of plasma protein in tumors.
Korngold and Pressman11 reported localization of antibodies labeled with 1131 in the Murphy-Sturm lymphosarcoma and Wagner's has found that virus in tumors is destroyed as the antibody level of the host rises. Babson and Winnick1 noted a greater uptake of isotope of biosynthetically-labeled plasma proteins by tumors than by liver and kidney. They found that the relative specific activities of two labeled amino acids was the same in plasma proteins and proteins of tumors and, further, the labeling of tumor protein was not affected by injection of large quantities of non-radioactive amino acids.
Our interest in this subject has developed from two lines of investigation. In studies on the metabolism of acetate-i-C14 and pyruvate-2-C14 in tissues of tumor-bearing rats, it was found that nontumor tissues rapidly transferred the isotope to amino acids. In experiments with acetate-1-C14, the isotope in nontumor tissues was found chiefly in glutamic acid and in experiments with pyruvate-2-C14, the isotope in nontumor tissues was found chiefly in glutamic acid and alanine.2"8 On the other hand, the tumors studied did not metabolize acetate-i-C14 and transferred the isotope of pyruvate-2-C14 primarily to lactate. These experiments suggested that the tumors might be dependent upon other tissues for their supply of <'non-essential amino acids" for protein synthesis.
Another suggestive line of investigation9 concerned transplantation experiments involving the Shope papilloma. It was found that adult rabbit skin infected in vitro with the Shope virus and transplanted to the brains of immune rabbits developed papillomas containing infectious virus. In like manner, the infectivity of the virus remained unchanged in domestic rabbit papillomas reinfected in vitro, despite growth in immune animals. In contrast, no evidence of virus could be found in the V2 carcinoma (the malignant tumor derived from the Shope papilloma) after similar treatment although infectious virus could be recovered after growth in normal nonimmune rabbits. These results suggest that antibody failed to penetrate the cells of normal skin or of benign papilloma but did penetrate the cells of the carcinoma and indicate that the transformation to cancer was associated with an increased permeability of cell walls.
The experimental questions which arose from these studies were: (i) could tumors take up plasma protein to a greater extent than other tissues, and (ii) could the tumors utilize these proteins for growth?
MATERIALS AND METHODS
The animals used in these experiments were male Sprague-Dawley rats weighing 150-200 grams. They were obtained from the Charles River Laboratories in Boston, Massachusetts, and were fed ad libitum on Purina Laboratory Chow. The Walker 256 carcinosarcoma and Jensen sarcoma used in these experiments were transplanted by Mrs. Rose K. Busch. The tumors were transplanted 7-9 days prior to the experiment -and weighed 3-5 grams in the aggregates of 2-4 sites of transplantation.
Glycine-2-C"' and DL-lysine-2-C'4, with specific activities of 19 microcuries per mg. and 3.3 microcuries per mg. respectively, were obtained from Tracerlab, Inc. In studies on the uptake of radioactive amino acids, 0.5 mg. of labeled glycine or 1 mg. of labeled lysine* was injected intraperitoneally into tumor-bearing rats. For preparation of the radioactive plasma, 2 mg. of labeled glycine or 10 mg. of labeled lysine were injected intraperitoneally into normal rats weighing 250-350 grams. At the end of the desired interval, generally three hours, the rats were anesthetized with nembutal (0.5 mg./100 grams body weight) and exsanguinated by arterial puncture at the bifurcation of the aorta by means of a 20 ml. syringe and a 19-gauge needle; 0.25 ml. of heparin (5000 U./ml.) were added to the syringe. The heparinized whole blood was centrifuged at 1500 r.p.m. for 10 minutes and the supernatant plasma was dialyzed for a minimum of two hours against a buffer of 0.1 M glycine or DL-lysine and 0.01 M sodium phosphate buffer at pH 7.4. An average of 375,000 c.p.m. (counts per minute) was found in 5 ml. of plasma and the average specific activity of the plasma protein was 1100 c.p.m./mg. At three hours after intravenous injection of 3-5 ml. of the radioactive plasma into tumor-bearing rats, the average specific activity of plasma proteins of the recipient rats was 280 c.p.m./mg.
At the selected time, the tumor-bearing rats receiving the radioactive tracer were anesthetized with nembutal and exsanguinated as noted above. The tissues were excised and placed in liquid air' except in experiments in which the cellular particulates were isolated by differential centrifugation. Following dispersion of the tissues in perchloric acid, the precipitated proteins were treated! with 5% trichloroacetic acid, 95% ethanol, ethyl ether, chloroform-methanol (2: 1) twice,18 petroleum ether-acetone (1: 1), and butanol. The suspension of protein in butanol was placed on an alundum disk in a separated glass funnel on a filter flask connected to a vacuum line; suction was applied until the plate was dry. Radioactivity was determined in a preflush flow counter.
In experiments involving differential centrifugation of the homogenates, the excised tissues were placed in ice-cold saline and then dispersed in 0. by protein of tumors is not significantly different from that of nontumor tissues. While the increase in specific activity of protein of the rapidly growing Walker 256 carcinosarcoma was equal to that of liver, values for protein of the Jensen sarcoma, a more slowly growing tumor, were lower than those of liver or kidney. The curves reached a plateau in the 3-6-hour interval. The specific activity of proteins of skeletal muscle was very low throughout the study. shown that values for intestinal mucosa were much higher than those of kidney, liver, or plasma, and slightly higher than pancreas. The specific activities of proteins of the heart, testis, thymus, and brain were determined at three hours after injection of the labeled glycine and these values ranged between those of muscle and kidney (Fig. 2) . In studies with DL-lysine-2-C14, essentially the same findings were obtained three hours after injection of the tracer. The specific activity of protein of the Walker 256 carcinosarcoma approximated that of liver or spleen (Fig. 1) , while the specific activity of protein of the pancreas was three to four times that of protein of the spleen (Fig.   2) . Values for lung, ,kidney, and muscle decreased in the same order as with glycine-2-C14.
PLASMA PROTEIN
The rates of uptake of isotope of plasma protein by protein of tissues is indicated in Figure 3 . The specific activity of protein of the tumors increased steadily in the first four hours after injection of the labeled plasma; no significant differences were found in the data for the Jensen sarcoma and the Walker 256 carcinosarcoma. The rate of increase of the specific activity of protein of the tumors was 23/2-10 times that of other tissues (Fig. 3) .
The curves for kidney and spleen reached a plateau in the 3-6-hour period, while that for liver began to decline after the third hour. The specific activity of protein of skeletal muscle was very low at each time point studied. At three hours after injection of the labeled protein, values for the specific activity of protein of the tumor were 3541 c.p.m./mg. (Fig. 4) compared with a range of 11-14 c.p.m./mg. for heart, diaphragm, spleen, kidney, thymus, and liver. Values for intestine, brain, testis, and lung ranged from 1.7-8.2 c.p.m./mg. and would appear in Figure 4 between pancreas and The possibility that isotope of plasma protein entered the protein of intracellular particulates was investigated by determination of the specific activity of proteins of these particulates after tissue homogenates had been subjected to differential centrifugation."0'1 Table 1 presents the specific activities of proteins of cellular particulates of Walker 256 carcinosarcoma, kidney, liver, and lung. Values for the nuclear fractions are not presented inasmuch as they closely reflected values of the whole homogenates; in these experiments no special precautions were taken for purification of the nuclei. The specific activities of proteins of the mitochondrial, microsomal, and supernatant fractions were sufficiently similar in experiments with either labeled glycine or lysine that the data were pooled in Table 1 . The data for mitochondria reflect the same trends as those for microsomes with the exception that the average value for lung was equal to that for tumor, although the variation was very great. The control experiments for these studies are presented in the specific activity of the cellular particulates was determined as in the in vivo experiments (Table 2) . From these studies, ratios could be obtained for the relative specific activities of proteins of the particulates and those of the supernatant fraction. In tumors, the ratio of the specific activity of protein of the mitochondrial fraction to that of the supernatant fraction varied from 1: 7 to 1: 9, and the corresponding values for the microsomal fraction were 1: 3.5 to 1: 5 in the in vitro studies. Since the specific activity of protein of the supernatant fraction of the tumor was 54 c.p.m./mg. in the in vivo experiments ( 
DISCUSSION
These initial experiments indicate a greater labeling of "tumor protein" than proteins of other tissues following injection of radioactive "plasma." It is clear that both "tumor protein" and "plasma" represent complex mixtures of proteins and other compounds. From the studies of Cohn and his co-workers,6 it is evident that there are many kinds of proteins in plasma and undoubtedly even the number of different antibodies is large. In experiments now in progress, radioactive plasma proteins are being separated by the methods developed by Cohn et al.6 and the isolated fractions are being reinjected into tumor-bearing rats. It remains to be determined whether one or many protein fractions contribute to the labeling of proteins of the tumor. On the other hand, "tumor protein" is a mixture of compounds which share the properties of insolubility in protein precipitants and organic solvents used for extraction of lipids. The nature of the proteins which are the recipients of the isotope of radioactive plasma has not been studied, but it seems possible that only a part of the proteins of the tumor can be synthesized from products of plasma proteins. In this case, an extensive study of the labeling of individual proteins of the tumor would be justified. Before an understanding of the mechanism of utilization of the plasma proteins can be achieved, specific proteins of tumors will have to be isolated and degraded. These studies do not permit evaluation of the extent of degradation of plasma protein before the fragments are incorporated into tumor protein.
While the possibility exists that the avidity displayed by the tumors These experiments may be of significance in three aspects of the study of neoplasia. First, the growth of the tumor in the starving animal and cachectic human may be related to its ability to trap plasma protein and utilize the degradation products for synthesis of tumor protein. Secondly, the ability of the tumor to invade and metastasize may reflect its more favorable nutritional requirements or conversely, the ability of the tumor to take up label of plasma protein may reflect cellular changes important to invasion and metastasis. Finally, the factors involved in concentration of the plasma protein may be related to differences between benign and malignant tumors in that the former may not effectively take up plasma proteins. SUMMARY 1. The rate of uptake of isotope of glycine-2-C14 and DL-lysine-2-CA4 by proteins of tumors was in the range for nontumor tissues over the period of 45 minutes to 6 hours following intraperitoneal injection of the isotope.
2. The rate of uptake of isotope of plasma proteins labeled with glycine-2-C14 or DL-lysine-2-CI4 by tumor protein was 2X2 to 10 times that of other tissues studied, with the exception of lung which gave variable results.
3. Labeling of microsomal fraction of tumor was 3.5 to 4.8 times greater than that of kidney, liver, and lung three hours after intravenous injection of labeled plasma protein.
4. Labeling of the mitochondrial fraction of tumors was 3.5 to 4.2 times greater than that of kidney and liver respectively three hours after intravenous injection of labeled plasma protein. 5 . It can be calculated from the data on labeling of tumor protein that uptake of plasma protein could account for the doubling of the weight of tumors in 24 hours.
